Should I buy or sell Avanos Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVNS shares. View AVNS analyst ratings or view top-rated stocks .

What is Avanos Medical's stock price target for 2024?

2 equities research analysts have issued 1-year price objectives for Avanos Medical's stock. Their AVNS share price targets range from $31.00 to $31.00. On average, they predict the company's stock price to reach $31.00 in the next year. This suggests a possible upside of 64.5% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts .

How have AVNS shares performed in 2024?

Avanos Medical's stock was trading at $22.43 at the start of the year. Since then, AVNS stock has decreased by 16.0% and is now trading at $18.85. View the best growth stocks for 2024 here .

Are investors shorting Avanos Medical?

Avanos Medical saw a decline in short interest in March. As of March 31st, there was short interest totaling 1,180,000 shares, a decline of 11.9% from the March 15th total of 1,340,000 shares. Based on an average daily trading volume, of 291,100 shares, the short-interest ratio is presently 4.1 days. Approximately 2.6% of the company's stock are short sold. View Avanos Medical's Short Interest .

When is Avanos Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our AVNS earnings forecast .

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) issued its earnings results on Tuesday, February, 20th. The company reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by $0.01. The firm earned $173.30 million during the quarter, compared to analyst estimates of $170.43 million. Avanos Medical had a positive trailing twelve-month return on equity of 4.25% and a negative net margin of 8.76%. The company's revenue was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.60 earnings per share.

What ETF holds Avanos Medical's stock?

Invesco S&P SmallCap Health Care ETF holds 85,945 shares of AVNS stock, representing 0.78% of its portfolio.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical issued an update on its FY 2024 earnings guidance on Friday, February, 23rd. The company provided earnings per share guidance of 1.300-1.450 for the period. The company issued revenue guidance of $685.0 million-$705.0 million.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com . Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB) , CVS Health (CVS) , Pfizer (PFE) , Procter & Gamble (PG) , Johnson & Johnson (JNJ) , RTX (RTX) , AT&T (T) , Abbott Laboratories (ABT) and Alibaba Group (BABA) .

How do I buy shares of Avanos Medical?

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:AVNS

Avanos Medical (AVNS) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free AVNS Stock Alerts

$18.85

+0.34 (+1.84%)

(As of 04/15/2024 ET)

Compare

Today's Range: $18.44
▼
$18.98
50-Day Range: $18.51
▼
$19.94
52-Week Range: $17.24
▼
$31.31

Volume: 293,279 shs
Average Volume: 288,339 shs
Market Capitalization: $870.93 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $31.00

Get Avanos Medical alerts:

Avanos Medical MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 64.5% Upside
$31.00 Price Target
Short Interest: Healthy
2.61% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$152,960 Sold Last Quarter
Proj. Earnings Growth: 33.33%
From $1.38 to $1.84 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.90 out of 5 stars

Medical Sector

201st out of 929 stocks

Surgical Appliances & Supplies Industry

7th out of 18 stocks

3.3

Analyst's Opinion

Consensus Rating
Avanos Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Avanos Medical has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
2.61% of the float of Avanos Medical has been sold short.
Short Interest Ratio / Days to Cover
Avanos Medical has a short interest ratio ("days to cover") of 4.1.
Change versus previous month
Short interest in Avanos Medical has recently decreased by 11.94%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Avanos Medical does not currently pay a dividend.
Dividend Growth
Avanos Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AVNS.

2.8

News and Social Media Coverage

News Sentiment
Avanos Medical has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Avanos Medical this week, compared to 2 articles on an average week.
Search Interest
2 people have searched for AVNS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Avanos Medical insiders have sold 1,441.16% more of their company's stock than they have bought. Specifically, they have bought $9,925.00 in company stock and sold $152,960.00 in company stock.
Percentage Held by Insiders
Only 2.90% of the stock of Avanos Medical is held by insiders.
Percentage Held by Institutions
95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Avanos Medical are expected to grow by 33.33% in the coming year, from $1.38 to $1.84 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Avanos Medical is -14.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Avanos Medical is -14.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Avanos Medical has a PEG Ratio of 1.08. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Avanos Medical has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Avanos Medical Stock (NYSE:AVNS)

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AVNS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AVNS Stock News Headlines

March 16, 2024 | insidertrades.com

Avanos Medical, Inc. (NYSE:AVNS) CFO Michael Greiner Sells 8,000 Shares

February 22, 2024 | finance.yahoo.com

Avanos Medical Full Year 2023 Earnings: US$0.21 loss per share (vs US$1.08 profit in FY 2022)

April 15, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

February 22, 2024 | markets.businessinsider.com

Avanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product Recall

February 21, 2024 | finance.yahoo.com

Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall

February 21, 2024 | prnewswire.com

Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall

February 21, 2024 | finance.yahoo.com

Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call Transcript

February 20, 2024 | msn.com

Supplementary Review: Avanos Medical (AVNS), February 20, 2024

April 15, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

February 20, 2024 | seekingalpha.com

Avanos Medical, Inc. 2023 Q4 - Results - Earnings Call Presentation

February 20, 2024 | msn.com

Avanos Medical reports mixed Q4 results; initiates FY24 outlook

February 20, 2024 | finance.yahoo.com

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results

February 20, 2024 | finance.yahoo.com

Avanos Medical Inc (AVNS) Reports Mixed 2023 Financial Results Amid Transformation Initiative

February 20, 2024 | prnewswire.com

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results

February 17, 2024 | finance.yahoo.com

AVNS Mar 2024 20.000 call

February 16, 2024 | msn.com

Avanos Medical Q4 2023 Earnings Preview

February 15, 2024 | finance.yahoo.com

Avanos Medical, Inc. (AVNS)

February 14, 2024 | markets.businessinsider.com

Analysts Are Neutral on These Healthcare Stocks: Avanos Medical (AVNS), Incyte (INCY)

February 14, 2024 | prnewswire.com

Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results

January 22, 2024 | finance.yahoo.com

New Strong Sell Stocks for January 9th

January 22, 2024 | finance.yahoo.com

New Strong Sell Stocks for January 12th

January 22, 2024 | finance.yahoo.com

New Strong Sell Stocks for January 16th

January 5, 2024 | benzinga.com

Avanos Medical Stock (NYSE:AVNS), Short Interest Report

January 5, 2024 | finance.yahoo.com

Avanos (AVNS) Preliminary Q4 Revenues Dampened by Lower Sales

January 5, 2024 | benzinga.com

Avanos Medical Stock (NYSE:AVNS) Dividends: History, Yield and Dates

January 4, 2024 | marketwatch.com

Avanos Medical Warns of 4Q, 2024 Sales Shortfalls

January 4, 2024 | msn.com

Avanos Medical down 12%, gives Q4 and FY guidance

See More Headlines

Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NYSE:AVNS
CUSIP: N/A
CIK: 1606498
Web: avanos.com
Phone: (844) 428-2667
Fax: N/A
Employees: 3,771
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $31.00
High Stock Price Target: $31.00
Low Stock Price Target: $31.00
Potential Upside/Downside: +65.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.32)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 13.59
P/E Growth: 1.08
Net Income: $-61,800,000.00
Net Margins: -8.76%
Pretax Margin: -1.17%
Return on Equity: 4.25%
Return on Assets: 3.11%

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 2.08
Quick Ratio: 1.38

Sales & Book Value

Annual Sales: $673.30 million
Price / Sales: 1.29
Cash Flow: $2.05 per share
Price / Cash Flow: 9.15
Book Value: $26.63 per share
Price / Book: 0.70

Miscellaneous

Outstanding Shares: 46,200,000
Free Float: 44,383,000
Market Cap: $866.71 million
Optionable: Optionable
Beta: 0.96

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Joseph F. Woody (Age 58)
CEO & Director
Comp: $2.21M
Mr. Michael C. Greiner (Age 51)
Senior VP, CFO & Chief Transformation Officer
Comp: $986.42k
Ms. Mojirade James (Age 57)
Senior VP, General Counsel & Corporate Secretary
Comp: $728.66k
Mr. Kerr W. Holbrook (Age 57)
Senior VP & Chief Commercial Officer
Comp: $747.61k
Mr. Sudhakar Varshney (Age 47)
Senior Vice President of Global Supply Chain & Procurement
Comp: $1.02M
Mr. John Joseph Hurley
Principal Accounting Officer & Controller
Mr. David Crawford
VP of FP&A and Investor Relations and Treasurer
Ms. Michelle Scharfenberg
Senior VP and Chief Ethics & Compliance Officer
Mr. Scott Galovan
Vice President of Strategy & Corporate Development
John W. Cato
Vice President of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AVNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVNS shares.
View AVNS analyst ratings or view top-rated stocks.
What is Avanos Medical's stock price target for 2024?: 2 equities research analysts have issued 1-year price objectives for Avanos Medical's stock. Their AVNS share price targets range from $31.00 to $31.00. On average, they predict the company's stock price to reach $31.00 in the next year. This suggests a possible upside of 64.5% from the stock's current price.
View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts.
How have AVNS shares performed in 2024?: Avanos Medical's stock was trading at $22.43 at the start of the year. Since then, AVNS stock has decreased by 16.0% and is now trading at $18.85.
View the best growth stocks for 2024 here.
Are investors shorting Avanos Medical?: Avanos Medical saw a decline in short interest in March. As of March 31st, there was short interest totaling 1,180,000 shares, a decline of 11.9% from the March 15th total of 1,340,000 shares. Based on an average daily trading volume, of 291,100 shares, the short-interest ratio is presently 4.1 days. Approximately 2.6% of the company's stock are short sold.
View Avanos Medical's Short Interest.
When is Avanos Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our AVNS earnings forecast.
How were Avanos Medical's earnings last quarter?: Avanos Medical, Inc. (NYSE:AVNS) issued its earnings results on Tuesday, February, 20th. The company reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by $0.01. The firm earned $173.30 million during the quarter, compared to analyst estimates of $170.43 million. Avanos Medical had a positive trailing twelve-month return on equity of 4.25% and a negative net margin of 8.76%. The company's revenue was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.60 earnings per share.

What ETF holds Avanos Medical's stock?: Invesco S&P SmallCap Health Care ETF holds 85,945 shares of AVNS stock, representing 0.78% of its portfolio.
What guidance has Avanos Medical issued on next quarter's earnings?: Avanos Medical issued an update on its FY 2024 earnings guidance on Friday, February, 23rd. The company provided earnings per share guidance of 1.300-1.450 for the period. The company issued revenue guidance of $685.0 million-$705.0 million.
What is Joseph F. Woody's approval rating as Avanos Medical's CEO?: 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Avanos Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).
How do I buy shares of Avanos Medical?: Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVNS) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Avanos Medical (AVNS) Stock Price, News & Analysis

Avanos Medical MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Avanos Medical Stock (NYSE:AVNS)

AVNS Stock Price History

AVNS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AVNS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™